Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neck

Table 2 Response to induction chemotherapy and chemoradiation therapy

	Primary lesion (n = 35)		Lymph node (n = 25)
Response	No.	%	No.	%
After induction chemotherapy
CR	18	51.4	7	28
PR	11	31.4	13	52
SD	1	2.9	1	4
PD	0	0	0	0
Non-assessable	5	14.2	4	16
Combined response (Primary lesion + LN)
CR
No.	9
%	25.7
ORR (CR + PR)
No.	30
%	85.7
After Concomitant chemoradiation
CR	24	68.6	17	68
PR	6	17.1	4	16
SD	0	0	0	0
PD	0	0	0	0
Combined response
CR
No.	22
%	62.8
ORR (CR + PR)
No.	30
%	85.7

Abbreviations: LN, regional neck lymph nodes; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, overall response rate.

ISSN: 1471-2407